In these trials, significant weight loss was demonstrated with liraglutide 3.0 mg therapy, compared to placebo (8.0% in SCALE obesity and prediabetes, 6.0% in SCALE-diabetes)
And what really frustrates people is that GLP-1 is something the body already makes, but companies tweak it just enough to patent it and then act like they own it ***Theres no reason one company should control a natural hormone just because they made a small modification
GLP Patch Reviews, Ledisa, and Before and After Photos: How to Read Them This is where most people get stuck, because marketing can feel like evidence
The third receptor target unique to Retatrutide among current obesity compounds
Unregulated medicines may be unsafe and contain unknown substances
Its a conversation that should be held between each patient and their practitioner to weigh the risks of continuing with the medication versus the risks of stopping, Dr